Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Blood Tau Fragment Elevated in Advanced CTE, Studies Find

Blood Tau Fragment Elevated in Advanced CTE, Studies Find

November 19, 2026 Health Desk Health

A blood marker for chronic traumatic encephalopathy moved closer to reality this week, as two research teams published evidence that a specific tau fragment is markedly elevated in former American football players with advanced CTE.

The studies appeared Thursday in JAMA, Footballerei reported.

Until now, CTE could be diagnosed with certainty only after death, through autopsy of the brain. The two papers, Footballerei reported, suggest that a tau fragment circulating in blood could change that — though both teams caution the test remains far from clinical use.

  • A tau fragment called eMTBR-tau was clearly elevated in the blood of former football players who later proved to have advanced CTE at autopsy, per two studies published in JAMA.
  • Advanced CTE could be distinguished from healthy brains with high accuracy; early stages could not yet be reliably detected.
  • Alzheimer’s disease produces even higher values, so a positive test only points toward CTE in players whose Alzheimer’s workup is negative and who have a history of repeated head injury.
  • Larger confirmatory studies are required before the marker can support a living diagnosis.

The consequence cuts to a long-standing clinical gap. If the pathology is only visible on the dissection table, no one can intervene while a patient is alive, and trials of potential therapies stall for want of a way to identify participants. A validated blood test would ease trial recruitment and give former players answers in life rather than after it.

Twenty-one brains, blood drawn first

The study published Thursday was led by Boston University and the Banner Health nonprofit network of Phoenix. It examined 21 former football players who had blood drawn while alive at the BU CTE Center and, upon their deaths, donated their brains to research, Footballerei reported.

Instagram

The autopsy findings were striking. Eighteen of the 21 had CTE, and 16 of those cases were advanced. Three had none. Among the donors were twelve professionals, seven college players and two from high school; in eleven of the twelve professionals the disease was already far advanced.

Researchers measured the tau fragment eMTBR-tau. Tau proteins form the characteristic deposits found in the brain in CTE and, separately, in Alzheimer’s disease. In advanced CTE, blood values ran significantly higher than in early-stage CTE or in donors without CTE, Footballerei reported.

“It’s a game changer,” said Michael Alosco, co-lead of clinical research at the BU CTE Center and one of the lead authors, while adding that researchers remain “in the discovery phase.”

A Washington University finding comes first

The result had a predecessor. On November 13, researchers at Washington University in St. Louis and the University of California, San Francisco reported similar findings in JAMA, Footballerei reported. That study had set out to examine an Alzheimer’s marker and determine whether it flagged other tau-related diseases — until one participant without Alzheimer’s turned up with high values of the fragment eMTBR-tau243.

The autopsy settled it: advanced CTE. Across eleven brain donors with confirmed CTE, blood levels ran above those of healthy people and rose with disease severity, per the study. Advanced CTE separated from healthy brains with high accuracy; early stages did not.

Alzheimer’s complicates the picture. Levels in Alzheimer’s disease are substantially higher, so the fragment alone cannot distinguish the two conditions.

“This will not be a standalone biomarker,” said Chihiro Sato, co-author of the Washington University study.

In her team’s reading, an elevated value could point toward CTE only when two conditions align: a documented history of repeated head injuries and a negative Alzheimer’s test. That dual-check logic mirrors how clinicians would eventually need to apply the marker.

Discovery phase, not diagnosis

Both teams framed the results as an early step rather than a clinical tool. Larger studies must first confirm the findings, Footballerei reported, and the test is not yet suitable for diagnosis. Sample sizes in both papers were small — 21 donors in the Boston-led study, eleven confirmed CTE cases in the St. Louis work — and both relied on postmortem verification as the reference standard.

The biological signal still carries weight. The fragment tracked severity, not just presence: values rose with stage, and the 16 advanced cases drove the separation from every other group in the Boston cohort. For trial designers, that gradation is what matters — severity markers allow treatment studies to stratify participants and track progression, tasks that autopsy-based diagnosis can never support.

What remains unknown is at least as consequential. Neither team has shown that the marker detects early CTE, the stage at which intervention would matter most. Neither has shown how the values behave in living patients who never come to autopsy. The pathogenesis of CTE’s relationship to blood-borne tau remained, per the researchers’ stated caution, in the discovery phase.

What a blood test would enable

The short-term payoff, the researchers indicate, is not a diagnostic but a research instrument. A validated severity marker would let investigators enroll players into therapy trials based on bloodwork rather than waiting for postmortem data that arrives, by definition, too late.

The longer-term payoff is personal.

The study’s lead institution, Boston University, is a private research university founded in 1839 by a group of Boston Methodists, with its original campus in Newbury, Vermont; it was chartered in Boston in 1869. Today it has nearly 38,000 students and more than 4,000 faculty members, and is classified among “R1: Doctoral Universities – Very high research activity.”

From its founding, its charter barred religious tests for instructors and opened every department equally regardless of sex or race, a provision unusual for its time. The university’s CTE Center, where the blood samples in the study were drawn, builds on that research mission.


Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

More on this story: Two Brain Regions Shrink Before Hippocampus in Early Alzheimer's Disease, Study Finds · Mayo Clinic Study: Blood Test Predicts Cognitive Impairment Risk 5-10 Years Ahead

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related reading

  • US Army to Detonate 5 Tons of Unstable Explosives in Iowa, Warning of Lead Dust Plume
  • Costa Rican Woman Fighting for Life After Husband’s Hatchet Attack

Related

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service